ALLO Stock Analysis: Buy, Sell, or Hold?
ALLO - Allogene Therapeutics, Inc. Common Stock
$1.87
0.03 (1.63%)
▲
5d:
+23.84%
30d:
+36.5%
90d:
+54.55%
HOLD
MODERATE Confidence
Last Updated: February 2, 2026
Earnings: Mar 12, 2026
Smart Money Distribution
ALLO is up 20.5% this week, but smart money is buying puts. Top strike: $1.5 2026-03-20 with 1 OI. Put ratio: 100% View Scanner →
Strength: 10.0/10
Get Alerted When ALLO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
3 traders called ALLO this week
40% bullish • 3 bearish
40% bullish • 3 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD - EXTENDED: ALLO is 9.4% above fair value ($1.71). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
📊 HOLD - EXTENDED: ALLO is 9.4% above fair value ($1.71). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
In-depth Analysis How we analyze
Valuation Analysis: ALLO is currently trading at $1.87, which is considered extended relative to its 30-day fair value range of $1.40 to $1.71.
Technical Outlook: Technically, ALLO is in a uptrend. The price is approaching resistance at $1.93. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: ALLO has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $7.38 (+301.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ALLO is in a uptrend. The price is approaching resistance at $1.93. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: ALLO has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $7.38 (+301.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$1.40 -
$1.71
Company Quality Score
61/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BEARISH: Price extended above range (+9.4% above fair value)
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 301.3% below Wall St target ($7.38)
Fair Price Analysis
30-Day Fair Range
$1.40 -
$1.71
Current vs Fair Value
EXTENDED
Support & Resistance Levels
Support Level
$1.45
Resistance Level
$1.93
Current Trend
Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-2.08
Wall Street Target
$7.38
(+301.3%)
Revenue Growth (YoY)
-100.0%
Last updated: February 02, 2026 3:36 PM ET
Data refreshes hourly during market hours. Next update: 4:36 PM
Data refreshes hourly during market hours. Next update: 4:36 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ALLO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Geoffrey M Parker
SELL
36744 shares
2025-10-21
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$514 | 63 BUY |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$91 | 62 BUY |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$847 | 54 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$89 | 62 BUY |
|
INSM
Insmed Inc |
STRONG BUY
19 analysts |
$215 | 53 HOLD |
